CAH Cardinal Health, Inc.
$234.57▼ -0.61%
Healthcare
Other
After hours
$234.57▲ +0.00%
Sep 11, 5:02 PM ET
Volume 1.11M
Avg Volume (10D) 1.40M
Key Metrics & Fundamentals
Market Cap
$54.56B
P/E Ratio
32.7
Div Yield
0.87%
52W Range
145.87 - 258.30
% vs 50 MA
0.13%
% vs 200 MA
8.42%
RSI-14
47.1
MACD Histogram
-0.4800
Beta (1Y vs SPY)
-0.06
Free Cash Flow
$1.43B
Gross Rev
$63.67B
Gross Profit
$2.56B
EBITDA
$1.08B
COGS
$61.11B
Operating Exp
$1.75B
Operating Income
$814.00M
EBIT
$814.00M
Pretax Income
$554.00M
Net Income
$398.00M
EPS (Diluted)
1.70
Price & Volume History
Loading chart…
Recent News
CAH Gains More Than 29% in 4 Months: Will the Uptrend Continue?
Zacks · Sep 11, 2026 6:21 PM
Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?
Motley Fool · Sep 11, 2026 3:49 PM
Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Motley Fool · Sep 11, 2026 3:29 PM
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
Motley Fool · Sep 10, 2026 5:46 PM
Amgen vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?
Motley Fool · Sep 10, 2026 4:21 PM
Cardinal (CAH) Up 2.5% Since Last Earnings Report: Can It Continue?
Zacks · Sep 10, 2026 3:30 PM
Jim Cramer Picks J&J (JNJ) Over Eli Lilly (LLY) and Pfizer (PFE) Among These Healthcare Stocks
Insider Monkey · Sep 9, 2026 7:12 PM
Cardinal Health (CAH) Declines More Than Market: Some Information for Investors
Zacks · Sep 8, 2026 10:00 PM
Is Cardinal Health Building a New Tech-Enabled Healthcare Platform?
Zacks · Sep 8, 2026 3:07 PM
McKesson Eyes $2.25B Precision Medicine Deal as Oncology Growth Accelerates
MarketBeat · Sep 8, 2026 1:02 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See CAH's money flow as a full page
Social Sentiment
Avg +0.20 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.